NCT05299411View on ClinicalTrials.gov

Intravenous Iron Infusion on Chemotherapy-induced Anemia

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions

Colon CancerChemotherapeutic-Induced Anemia

Interventions

DRUG

iron (isomaltoside)

iron supplement through intravenous infusion

DRUG

Dried Ferrous Sulfate

iron supplement through oral intake

Sponsors

Collaborators (1)

Pharmbio Korea Inc.

All Listed Sponsors

collaborator

Pharmbio Korea Inc.

UNKNOWN

lead

Korea University Guro Hospital

OTHER

NCT05299411 - Intravenous Iron Infusion on Chemotherapy-induced Anemia | Biotech Hunter | Biotech Hunter